These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20158186)

  • 1. 1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonists.
    Widler L; Altmann E; Beerli R; Breitenstein W; Bouhelal R; Buhl T; Gamse R; Gerspacher M; Halleux C; John MR; Lehmann H; Kalb O; Kneissel M; Missbach M; Müller IR; Reidemeister S; Renaud J; Taillardat A; Tommasi R; Weiler S; Wolf RM; Seuwen K
    J Med Chem; 2010 Mar; 53(5):2250-63. PubMed ID: 20158186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel and potent orally active calcium-sensing receptor antagonists that stimulate pulselike parathyroid hormone secretion: synthesis and structure-activity relationships of tetrahydropyrazolopyrimidine derivatives.
    Yoshida M; Mori A; Kotani E; Oka M; Makino H; Fujita H; Ban J; Ikeda Y; Kawamoto T; Goto M; Kimura H; Baba A; Yasuma T
    J Med Chem; 2011 Mar; 54(5):1430-40. PubMed ID: 21306167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats.
    Kimura S; Nakagawa T; Matsuo Y; Ishida Y; Okamoto Y; Hayashi M
    Eur J Pharmacol; 2011 Oct; 668(1-2):331-6. PubMed ID: 21810422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans.
    John MR; Widler L; Gamse R; Buhl T; Seuwen K; Breitenstein W; Bruin GJ; Belleli R; Klickstein LB; Kneissel M
    Bone; 2011 Aug; 49(2):233-41. PubMed ID: 21514409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation.
    Kumar S; Matheny CJ; Hoffman SJ; Marquis RW; Schultz M; Liang X; Vasko JA; Stroup GB; Vaden VR; Haley H; Fox J; DelMar EG; Nemeth EF; Lago AM; Callahan JF; Bhatnagar P; Huffman WF; Gowen M; Yi B; Danoff TM; Fitzpatrick LA
    Bone; 2010 Feb; 46(2):534-42. PubMed ID: 19786130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis.
    Widler L
    Future Med Chem; 2011 Apr; 3(5):535-47. PubMed ID: 21526895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists.
    Didiuk MT; Griffith DA; Benbow JW; Liu KK; Walker DP; Bi FC; Morris J; Guzman-Perez A; Gao H; Bechle BM; Kelley RM; Yang X; Dirico K; Ahmed S; Hungerford W; DiBrinno J; Zawistoski MP; Bagley SW; Li J; Zeng Y; Santucci S; Oliver R; Corbett M; Olson T; Chen C; Li M; Paralkar VM; Riccardi KA; Healy DR; Kalgutkar AS; Maurer TS; Nguyen HT; Frederick KS
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4555-9. PubMed ID: 19625189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and structure-activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists.
    Yang W; Ruan Z; Wang Y; Van Kirk K; Ma Z; Arey BJ; Cooper CB; Seethala R; Feyen JH; Dickson JK
    J Med Chem; 2009 Feb; 52(4):1204-8. PubMed ID: 19143533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and potent calcium-sensing receptor antagonists: discovery of (5R)-N-[1-ethyl-1-(4-ethylphenyl)propyl]-2,7,7-trimethyl-5-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide monotosylate (TAK-075) as an orally active bone anabolic agent.
    Yoshida M; Mori A; Morimoto S; Kotani E; Oka M; Notoya K; Makino H; Ono M; Shirasaki M; Tada N; Fujita H; Ban J; Ikeda Y; Kawamoto T; Goto M; Kimura H; Baba A; Yasuma T
    Bioorg Med Chem; 2011 Mar; 19(6):1881-94. PubMed ID: 21353570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.
    Marquis RW; Lago AM; Callahan JF; Rahman A; Dong X; Stroup GB; Hoffman S; Gowen M; DelMar EG; Van Wagenen BC; Logan S; Shimizu S; Fox J; Nemeth EF; Roethke T; Smith BR; Ward KW; Bhatnagar P
    J Med Chem; 2009 Nov; 52(21):6599-605. PubMed ID: 19821575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women.
    John MR; Harfst E; Loeffler J; Belleli R; Mason J; Bruin GJ; Seuwen K; Klickstein LB; Mindeholm L; Widler L; Kneissel M
    Bone; 2014 Jul; 64():204-10. PubMed ID: 24769332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA.
    Nielsen PK; Rasmussen AK; Butters R; Feldt-Rasmussen U; Bendtzen K; Diaz R; Brown EM; Olgaard K
    Biochem Biophys Res Commun; 1997 Sep; 238(3):880-5. PubMed ID: 9325185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.
    Marquis RW; Lago AM; Callahan JF; Trout RE; Gowen M; DelMar EG; Van Wagenen BC; Logan S; Shimizu S; Fox J; Nemeth EF; Yang Z; Roethke T; Smith BR; Ward KW; Lee J; Keenan RM; Bhatnagar P
    J Med Chem; 2009 Jul; 52(13):3982-93. PubMed ID: 19492813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo.
    Arey BJ; Seethala R; Ma Z; Fura A; Morin J; Swartz J; Vyas V; Yang W; Dickson JK; Feyen JH
    Endocrinology; 2005 Apr; 146(4):2015-22. PubMed ID: 15637285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone.
    Nemeth EF; Delmar EG; Heaton WL; Miller MA; Lambert LD; Conklin RL; Gowen M; Gleason JG; Bhatnagar PK; Fox J
    J Pharmacol Exp Ther; 2001 Oct; 299(1):323-31. PubMed ID: 11561095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the treatment of osteoporosis.
    Kalgutkar AS; Griffith DA; Ryder T; Sun H; Miao Z; Bauman JN; Didiuk MT; Frederick KS; Zhao SX; Prakash C; Soglia JR; Bagley SW; Bechle BM; Kelley RM; Dirico K; Zawistoski M; Li J; Oliver R; Guzman-Perez A; Liu KK; Walker DP; Benbow JW; Morris J
    Chem Res Toxicol; 2010 Jun; 23(6):1115-26. PubMed ID: 20507089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis.
    Liang GB; Zhou C; Huo X; Wang H; Yang X; Huang S; Wang H; Wilkinson H; Luo L; Tang W; Sutton D; Li H; Zaller D; Meinke PT
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4077-80. PubMed ID: 27397499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis.
    Shcherbakova I; Balandrin MF; Fox J; Ghatak A; Heaton WL; Conklin RL
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1557-60. PubMed ID: 15745796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship of tetrahydropyrazolopyrimidine derivatives--a novel structural class of potent calcium-sensing receptor antagonists.
    Yoshida M; Mori A; Inaba A; Oka M; Makino H; Yamaguchi M; Fujita H; Kawamoto T; Goto M; Kimura H; Baba A; Yasuma T
    Bioorg Med Chem; 2010 Dec; 18(24):8501-11. PubMed ID: 21055954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of an orally efficacious positive allosteric modulator of the calcium sensing receptor containing a dibenzylamine core.
    Harrington PE; St Jean DJ; Clarine J; Coulter TS; Croghan M; Davenport A; Davis J; Ghiron C; Hutchinson J; Kelly MG; Lott F; Lu JY; Martin D; Morony S; Poon SF; Portero-Larragueta E; Reagan JD; Regal KA; Tasker A; Wang M; Yang Y; Yao G; Zeng Q; Henley C; Fotsch C
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5544-7. PubMed ID: 20708930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.